Position in DRMA
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$12,900
New position
Shares Held
10,000
first reported quarter
Ownership
0.249%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 13 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Advisory Alpha, LLC holds $2,276,517 across 6 Biotechnology names. DRMA ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,999 | $992,963 | |
| 2 | TECH |
BIO-TECHNE Corp
|
7,581 | $535,597 | |
| 3 | INCY |
Incyte Corp
|
3,844 | $435,755 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
4,378 | $250,509 | |
| 5 | AVXL |
Anavex Life Sciences Corp.
|
18,839 | $48,793 | |
| 6 | DRMA |
Dermata Therapeutics, Inc.
This page
|
10,000 | $12,900 |
All Filings in DRMA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,900 | 10,000 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||